查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1677041

精准诊断和医疗市场（按产品、技术、应用和最终用户划分）- 2025-2030 年全球预测

Precision Diagnostics & Medicine Market by Product, Technology, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

精准诊断和医疗保健市场预计在 2024 年价值为 1,602.1 亿美元，在 2025 年成长至 1,768.2 亿美元，到 2030 年达到 2,997.1 亿美元，复合年增长率为 11.00%。

主要市场统计数据
基准年 2024 年 1602.1亿美元
预计 2025 年 1768.2亿美元
预测年份 2030 2997.1亿美元
复合年增长率（%） 11.00％

精准诊断和医疗市场正在经历前所未有的变革时期，其驱动力包括技术的快速创新、医疗保健需求的不断增长以及个人化医疗的广泛转变。在当今动态的环境中，诊断的准确性和疾病的早期发现对于有效的治疗策略至关重要。从生物技术和资料科学到临床创新，多学科专业知识的融合正在为重新定义疾病的检测和管理方式的突破铺平道路。

该报告针对行业领导者、投资者和决策者，对市场的多个层面进行了深入分析。读者将全面了解新兴趋势、特定产业的挑战和不断变化的竞争格局。该分析强调了有针对性的研究和战略远见的价值，并强调了将技术投资与市场需求相结合的重要性。

随着诊断和治疗性介入之间的界线变得越来越模糊，医疗保健对精准性的需求从未如此强烈。技术创新不仅改善了患者的治疗效果，而且还促进了根据每个患者的基因和分子特征制定个人化治疗方法的开发。本介绍性概述为深入探讨变革性的市场变化、细分细微差别和可操作的建议奠定了基础，这些建议可以为这个快速发展的行业制定面向未来的策略。

精准诊断与医疗市场转型

市场正在经历一场重塑其基本格局的转型变革。数位健康技术、人工智慧和资料分析的前所未有的进步正在推动诊断工具和平台的发展。这些技术不仅提高了诊断结果的准确性，还能即时整合病患讯息，从而做出更准确、及时的治疗决策。

世界各地的法规结构正在不断发展，以支持创新，同时确保病患安全和资料隐私。这些监管变化刺激了对研发的投资增加，促进了开发灵活且能够回应医疗保健系统动态需求的新型诊断平台。此外，基因组学、分子诊断学和蛋白质组学日益融入常规临床实践，正在加速市场成长并促使人们重新思考传统的诊断方法。

业内公司透过投资次世代定序和先进成像系统等技术不断适应这一新环境。这些投资对于使产品能力与新兴临床需求保持一致至关重要。市场转型的轨迹体现了技术创新与以患者为中心的护理之间的动态相互作用，这为医疗保健服务树立了新的标准。

市场成长的关键细分洞察

仔细观察市场区隔就会发现复杂的层面，这对于理解精准诊断和医疗产业的成长轨迹至关重要。就产品而言，市场分为消耗品和设备。消耗品进一步分为套件、检测试剂和试剂，而设备则分为分析仪、成像系统和定序仪。

基于技术的细分进一步增加了分析的深度，透过基因组学、分子诊断学和蛋白质组学来描述市场特征。在分子诊断领域，次世代定序和聚合酵素链锁反应过程的进一步改进正在推动市场大部分创新动能。这种技术分层不仅突显了尖端的进步，也突显了从传统方法转向更先进的整合系统的转变。

按应用细分可以发现不同的市场领域，例如疾病诊断、精准医疗和研究与发展。各应用领域进一步细分：疾病诊断着重于慢性病和遗传疾病，精准医疗着重于个人化医疗和标靶治疗。此外，最终用户部分还全面介绍了临床实验室（包括诊断和研究实验室）和医院的使用情况。这种多方面的细分框架为相关人员提供了对市场潜力和策略发展途径的关键见解。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球慢性病发生率不断上升
      • 全球对个人化医疗解决方案的需求不断增加
      • 政府采取措施在世界各地推动精准诊断
    • 限制因素
      • 精准诊断和个人化治疗的严格合规要求
    • 机会
      • 生物製药研究的激增支持了生物标记的发现和检验技术
      • 基因组技术的进步使个人化治疗计划成为可能
    • 任务
      • 将精准诊断技术融入传统医疗保健系统的挑战
  • 市场区隔分析
    • 产品：用于精确疾病检测和监测的套件和检测方法越来越受欢迎
    • 应用：拓展应用领域至精准诊断、精准医疗
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 精准诊断及医疗市场（分产品）

  • 耗材
    • 套件和检测试剂
    • 试剂
  • 装置
    • 分析器
    • 影像系统
    • 定序仪

第七章 精准诊断及医疗市场（按技术）

  • 基因组学
  • 分子诊断
    • 次世代定序
    • 聚合酵素链锁反应
  • 蛋白质体学

第 8 章 精准诊断与医疗市场应用分析

  • 疾病诊断
    • 慢性病
    • 遗传性疾病
  • 精准治疗
    • 个人化医疗
    • 标靶治疗
  • 研究与开发

第九章 精准诊断及医疗市场（依最终用户）

  • 临床实验室
    • 诊断实验室
    • 研究部门
  • 医院

第 10 章：美洲精准诊断与医疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太精准诊断及医疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 12 章欧洲、中东和非洲的精准诊断与医疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Abbott Laboratories
  • AstraZeneca PLC
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Technologies, Inc.
  • Illumina, Inc.
  • International Business Machines Corp.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • Medtronic PLC
  • Myriad Genetics Inc.
  • Novartis AG
  • OneOme, LLC
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Siemens Healthineers
  • Swiss Precision Diagnostics GmbH
  • Thermo Fisher Scientific Inc.
Product Code: MRR-50750BF5CD44

The Precision Diagnostics & Medicine Market was valued at USD 160.21 billion in 2024 and is projected to grow to USD 176.82 billion in 2025, with a CAGR of 11.00%, reaching USD 299.71 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 160.21 billion
Estimated Year [2025] USD 176.82 billion
Forecast Year [2030] USD 299.71 billion
CAGR (%) 11.00%

The precision diagnostics and medicine market is undergoing a period of unprecedented transformation, driven by rapid technological innovations, increasing healthcare demands, and a broader shift towards individualized patient care. In today's dynamic environment, diagnostic accuracy and early disease identification have become pivotal for effective treatment strategies. The convergence of multidisciplinary expertise-from biotechnology and data science to clinical innovation-has paved the way for breakthroughs that redefine how diseases are detected and managed.

This report provides an in-depth analysis aimed at guiding industry leaders, investors, and decision-makers through the multifaceted layers of the market. Within these pages, readers will find comprehensive insights into emerging trends, sector-specific challenges, and the evolving competitive landscape. Emphasizing the value of targeted research and strategic foresight, the analysis underscores the importance of harmonizing technological investments with market demands.

As the line between diagnostics and therapeutic interventions continues to blur, the need for precision in medicine has never been more critical. Innovations are not only improving patient outcomes but are also fostering the development of personalized treatment modalities tailored to the genetic and molecular profiles of individual patients. This introductory overview sets the stage for a detailed exploration of the market's transformative shifts, segmentation nuances, and actionable recommendations that form the backbone of a forward-looking strategy in this rapidly evolving industry.

Transformative Shifts in the Precision Diagnostics & Medicine Landscape

The market is experiencing transformative shifts that are reshaping its foundational landscape. Unprecedented advancements in digital health technologies, artificial intelligence, and data analytics are driving the evolution of diagnostic tools and platforms. These technologies are not only augmenting the accuracy of diagnostic results but are also enabling real-time integration of patient information, leading to more precise and timely treatment decisions.

Regulatory frameworks across global jurisdictions are evolving to support innovations while ensuring patient safety and data privacy. Such regulatory changes are spurring greater levels of investment in R&D, catalyzing the development of novel diagnostics platforms that are more agile and responsive to the dynamic needs of healthcare systems. Moreover, the increasing convergence of genomics, molecular diagnostics, and proteomics with everyday clinical practices is accelerating market growth and prompting a rethinking of conventional diagnostic methodologies.

Industry players are continuously adapting to this new environment by investing in next-generation sequencing and advanced imaging systems, among other technologies. These investments are essential to align product capabilities with emerging clinical needs. The market's transformative trajectory illustrates a dynamic interplay between technological innovation and patient-centric care that is setting a new standard in the delivery of health services.

Key Segmentation Insights for Market Growth

A granular examination of market segmentation reveals intricate layers that are pivotal for understanding growth trajectories in the precision diagnostics and medicine arena. When viewed through the lens of product, the market is delineated into consumables and instruments. Consumables have further been dissected into kits, assays, and reagents, while instruments are categorized into analyzers, imaging systems, and sequencers; each subgroup responds to unique operational demands and technological advancements.

Technology-based segmentation offers additional depth to the analysis, characterizing the market through genomics, molecular diagnostics, and proteomics. Within the sphere of molecular diagnostics, further refinement is seen in next-generation sequencing and polymerase chain reaction processes, which anchor much of the market's innovative momentum. This technological stratification not only highlights the cutting-edge advancements but also underscores the transition from traditional methodologies to more advanced, integrated systems.

When segmentation is approached by application, distinct market niches emerge such as disease diagnosis, precision therapeutics, and research and development. Each application area is further broken down to focus on chronic diseases and genetic disorders under disease diagnosis, and personalized medicine and targeted therapies within precision therapeutics. In addition, the end-user segment provides a comprehensive look at utilization by clinical laboratories-with diagnostic and research laboratories-and hospitals. This multidimensional segmentation framework offers stakeholders critical insight into market potentials and strategic avenues for targeted development.

Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Kits & Assays and Reagents. The Instruments is further studied across Analyzers, Imaging Systems, and Sequencers.

Based on Technology, market is studied across Genomics, Molecular Diagnostics, and Proteomics. The Molecular Diagnostics is further studied across Next-Generation Sequencing and Polymerase Chain Reaction.

Based on Application, market is studied across Disease Diagnosis, Precision Therapeutics, and Research & Development. The Disease Diagnosis is further studied across Chronic Diseases and Genetic Disorders. The Precision Therapeutics is further studied across Personalized Medicine and Targeted Therapies.

Based on End User, market is studied across Clinical Laboratories and Hospitals. The Clinical Laboratories is further studied across Diagnostic Laboratories and Research Laboratories.

Key Regional Insights in a Global Market

The geographic breakdown of the precision diagnostics and medicine market offers compelling insights into regional growth patterns and strategic priorities necessary to navigate a diverse global landscape. The Americas have long been a hotbed for innovation and capital investment, driven by robust healthcare infrastructures and advanced research ecosystems. Meanwhile, the region encompassing Europe, the Middle East, and Africa is witnessing rapid policy reforms and collaborative research initiatives that are fueling new opportunities in diagnostics and personalized medicine. Strategic partnerships in these regions are also expanding as public and private sectors align to address healthcare challenges.

Similarly, in the Asia-Pacific region, rapid economic growth combined with significant investments in healthcare infrastructure is driving market dynamism. Emerging economies in this region are experiencing a surge in the adoption of advanced diagnostic tools as governments bolster efforts towards healthcare modernization. The interplay between socio-economic advancements and technological health innovations is critical to understanding the regional developmental trajectories. Each of these regions presents unique regulatory, economic, and cultural factors which together shape the global dynamics of the market and offer varied opportunities for industry expansion.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation

A host of leading companies in the precision diagnostics and medicine space are playing pivotal roles in propelling market innovations forward. Influential players such as Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc. are laying the groundwork with their robust pipelines and strategic investments in next-generation diagnostics. Equally noteworthy are the contributions from Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, and Danaher Corporation, whose research and development efforts are shaping the future landscape of diagnostics and therapeutic interventions.

Global giants like F. Hoffmann-La Roche Ltd, GE Healthcare Technologies, Inc., and Illumina, Inc. continue to set benchmarks with their state-of-the-art technology and comprehensive service models. International Business Machines Corp., Johnson & Johnson Services, Inc., and Koninklijke Philips N.V. are making significant strides by blending clinical insights with technological innovation. Also contributing to this evolution are companies like Lantheus Medical Imaging, Inc., Medtronic PLC, Myriad Genetics Inc., and Novartis AG, all of which have capitalized on a combination of advanced research, strategic collaborations, and progressive market approaches. Innovators such as OneOme, LLC, Pfizer Inc., Qiagen NV, and Quest Diagnostics Incorporated are also vital components of this ecosystem, underscoring the competitive momentum. Leaders like Sanofi S.A., Siemens Healthineers, Swiss Precision Diagnostics GmbH, and Thermo Fisher Scientific Inc. further emphasize the strategic diversity and robust market positioning that define the future of this critical field.

The report delves into recent significant developments in the Precision Diagnostics & Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare Technologies, Inc., Illumina, Inc., International Business Machines Corp., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Medtronic PLC, Myriad Genetics Inc., Novartis AG, OneOme, LLC, Pfizer Inc., Qiagen NV, Quest Diagnostics Incorporated, Sanofi S.A., Siemens Healthineers, Swiss Precision Diagnostics GmbH, and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

To capitalize on the rapidly evolving landscape of precision diagnostics and medicine, industry leaders should consider a multi-pronged strategy that integrates innovation, strategic partnerships, and market diversification. It is imperative to increase investments in cutting-edge technologies, particularly in areas such as next-generation sequencing and imaging systems, to meet the growing demand for personalized diagnostics. Emphasizing collaborative research and development, especially across the boundaries of genomics, molecular diagnostics, and proteomics, will help accelerate product development cycles and enhance diagnostic accuracy.

A strong focus on regulatory compliance and proactive engagement with policy makers can yield significant competitive advantages. Leveraging emerging digital health tools to facilitate real-time data analytics and patient management can also streamline diagnostic workflows and improve clinical outcomes. Diversification within product and technology portfolios will allow companies to adapt quickly to market shifts and capitalize on emerging trends.

Furthermore, forging alliances with regional healthcare stakeholders can assist in tailoring products to localized needs, thereby strengthening market presence. Comprehensive market intelligence and scenario planning will be crucial in navigating the complexities of global markets while ensuring resilience in the face of disruptive innovations. These recommendations provide a strategic roadmap for leaders aiming to drive sustained growth and operational excellence in this fast-paced environment.

Conclusion: Driving Future Growth

The analysis underscores that precision diagnostics and medicine is positioned at the crossroads of transformation fueled by technological innovation and an unwavering commitment to patient-centricity. Recognizing the full potential of this market requires a deep understanding of its segmented structure, regional dynamics, and innovative company strategies. These insights are critical for developing robust strategies that not only respond to current market demands but also anticipate future trends.

This comprehensive examination highlights the momentum behind the integration of cutting-edge technologies with traditional diagnostic methods, thereby enabling substantial improvements in healthcare delivery. With strategic investment in research and development, proactive regulatory navigation, and a keen focus on market-specific nuances, industry leaders can unlock significant value. The convergence of diverse yet complementary factors is paving the way for a new era where precision diagnostics and medicine will play a central role in shaping global health outcomes. The path forward is clear: embracing innovation while remaining agile will be pivotal for achieving long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases globally
      • 5.1.1.2. Increasing demand for personalized healthcare solutions worldwide
      • 5.1.1.3. Government initiatives promoting precision diagnostics worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory compliance requirements in precision diagnostics and personalized treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in biopharmaceutical research supporting biomarker discovery and validation techniques
      • 5.1.3.2. Advancements in genomic technologies enabling personalized treatment plans
    • 5.1.4. Challenges
      • 5.1.4.1. Issues in integrating precision diagnostic techniques into legacy healthcare systems
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing preference for kits & assays for precise disease detection and monitoring
    • 5.2.2. Application: Expanding application of precision diagnostics and medicine in precision therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Precision Diagnostics & Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Kits & Assays
    • 6.2.2. Reagents
  • 6.3. Instruments
    • 6.3.1. Analyzers
    • 6.3.2. Imaging Systems
    • 6.3.3. Sequencers

7. Precision Diagnostics & Medicine Market, by Technology

  • 7.1. Introduction
  • 7.2. Genomics
  • 7.3. Molecular Diagnostics
    • 7.3.1. Next-Generation Sequencing
    • 7.3.2. Polymerase Chain Reaction
  • 7.4. Proteomics

8. Precision Diagnostics & Medicine Market, by Application

  • 8.1. Introduction
  • 8.2. Disease Diagnosis
    • 8.2.1. Chronic Diseases
    • 8.2.2. Genetic Disorders
  • 8.3. Precision Therapeutics
    • 8.3.1. Personalized Medicine
    • 8.3.2. Targeted Therapies
  • 8.4. Research & Development

9. Precision Diagnostics & Medicine Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
    • 9.2.1. Diagnostic Laboratories
    • 9.2.2. Research Laboratories
  • 9.3. Hospitals

10. Americas Precision Diagnostics & Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Precision Diagnostics & Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Precision Diagnostics & Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Precision Diagnostics announces the launch of VerifID, a solution that redefines sample authentication
    • 13.3.2. Aignostics accelerates precision diagnostics with a USD 34 million Series B funding for AI-driven pathology
    • 13.3.3. Danaher Corporation announced the launch of two new CLIA and CAP-certified labs
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AstraZeneca PLC
  • 3. Baxter International Inc.
  • 4. Becton, Dickinson and Company
  • 5. Biogen Inc.
  • 6. Bristol-Myers Squibb Company
  • 7. Danaher Corporation
  • 8. F. Hoffmann-La Roche Ltd
  • 9. GE Healthcare Technologies, Inc.
  • 10. Illumina, Inc.
  • 11. International Business Machines Corp.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Lantheus Medical Imaging, Inc.
  • 15. Medtronic PLC
  • 16. Myriad Genetics Inc.
  • 17. Novartis AG
  • 18. OneOme, LLC
  • 19. Pfizer Inc.
  • 20. Qiagen NV
  • 21. Quest Diagnostics Incorporated
  • 22. Sanofi S.A.
  • 23. Siemens Healthineers
  • 24. Swiss Precision Diagnostics GmbH
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET MULTI-CURRENCY
  • FIGURE 2. PRECISION DIAGNOSTICS & MEDICINE MARKET MULTI-LANGUAGE
  • FIGURE 3. PRECISION DIAGNOSTICS & MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 4. PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. PRECISION DIAGNOSTICS & MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. PRECISION DIAGNOSTICS & MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PRECISION DIAGNOSTICS & MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECISION DIAGNOSTICS & MEDICINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TARGETED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 120. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 128. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 130. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 138. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 146. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 148. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 150. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 158. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 160. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 165. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 168. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 170. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 173. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 180. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 183. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 188. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 190. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 193. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 203. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 205. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 210. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 213. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 218. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 220. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 223. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 225. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 228. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 230. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 244. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 246. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 249. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 251. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 254. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 256. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 259. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 261. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 264. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 267. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 269. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 271. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 274. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 276. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 277. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 279. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 281. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 282. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 284. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 287. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 291. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRECISION THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 292. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 294. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 296. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 299. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. ISRAEL PRECISION DIAGNOSTICS & MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 301. ISRAEL PRECISION DI